Clinical Trials Browser

Neuroendocrine Tumors × olaparib × Endocrine × Clear all

NCT04086485 2025-12-17

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Phase 1/2 Recruiting

Carcinoid Tumor, Neuroendocrine Tumors

NCT05870423 2025-06-05

PRRT-PARPi

Phase 1 Recruiting

Neuroendocrine Tumors

NCT06607692 2024-10-21

LUPARPED

Phase 2 Recruiting

CNSEndocrineNET

Adrenal Gland Neoplasms, Medulloblastoma, Meningioma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT04375267 2023-11-14

LuPARP

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors